tryptophan has been researched along with Drug Withdrawal Symptoms in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (60.00) | 18.7374 |
| 1990's | 8 (17.78) | 18.2507 |
| 2000's | 6 (13.33) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 1 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| Arnhard, K; Fuchs, D; Geisler, S; Gleissenthall, GV; Kemmler, G; Mechtcheriakov, S; Oberacher, H; Schurr, T; Unterberger, C | 1 |
| Ahmed, S; Batool, F; Haleem, DJ | 1 |
| Inoue, T; Kamba, T; Kamoto, T; Maeno, A; Nakamura, E; Ogawa, O; Shimizu, Y; Terada, N; Yoshida, T | 1 |
| Hruby, VJ; Keresztes, AI; Largent-Milnes, TM; Roeske, WR; Tumati, S; Vanderah, TW; Varga, EV; Yamamoto, T | 1 |
| Budac, DP; Gulinello, M; Li, Y; Pehrson, AL; Sánchez, C | 1 |
| Ilivitsky, V; Knott, V; Mahoney, C; Perugini, M; Young, SN | 1 |
| Epstein, OI; Pan, IR; Titkova, AM | 1 |
| Berlin, I; Manéglier, B; Spreux-Varoquaux, O; Vorspan, F; Warot, D | 1 |
| Bryant, SM; Kolodchak, J | 1 |
| Delgado, PL | 1 |
| Alphs, L; Davis, JM | 1 |
| Banki, CM | 1 |
| Herrera, E; Martín del Río, R; Mena, MA | 1 |
| Kruszewska, A; Langwiński, R | 1 |
| Colin, H; Friedman, MJ; Gaspar, M; Guiochon, G; Krstulović, AM; Pajer, KA | 1 |
| Charney, DS; Heninger, GR; Sternberg, DE | 1 |
| Badawy, AA; Evans, CM; Evans, M; Punjani, NF | 1 |
| Badawy, AA; Evans, M; Punjani, NF | 2 |
| Haleem, DJ; Haleem, MA; Yasmeen, A; Zafar, A | 1 |
| Darmani, NA | 1 |
| Fisher, H; Halladay, AK; Hsu, T; Sekowski, A; Wagner, GC | 1 |
| Badawy, AA; Evans, M | 3 |
| Agarwal, RA; Lapierre, YD; Rastogi, RB; Singhal, RL | 1 |
| Hoffman, P; Moses, F; Tabakoff, B | 1 |
| Brenner, A; Wapnir, RA | 1 |
| Bunney, WE; Kopanda, RT; Murphy, DL | 1 |
| Hartmann, E | 1 |
| Hoffman, PL; Tabakoff, B | 1 |
| Abu-Murad, C; Littleton, JM | 1 |
| Morgan, PF | 1 |
| Bowen, DJ; Fox, E; Spring, B | 1 |
| Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T | 1 |
| Chadwick, MJ; Gregory, DL; Wendling, G | 1 |
| Eagles, JM | 1 |
| Pike, RF | 1 |
| Schneider-Helmert, D; Spinweber, CL | 1 |
| Badawy, AA | 1 |
| Berman, ML; Tennant, F | 1 |
| Goldstein, DB | 1 |
| Algeri, S; Costa, E | 1 |
| Grahame-Smith, DG; Marshall, I | 1 |
| Norton, PR | 1 |
1 review(s) available for tryptophan and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Monoamine depletion studies: implications for antidepressant discontinuation syndrome.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder; Dopamine; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Synapses; Tryptophan | 2006 |
6 trial(s) available for tryptophan and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Effects of tryptophan depletion on acute smoking abstinence symptoms and the acute smoking response.
Topics: Adult; Affect; Analysis of Variance; Double-Blind Method; Electroencephalography; Humans; Male; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tryptophan | 2003 |
Effect of glucose on tobacco craving. Is it mediated by tryptophan and serotonin?
Topics: Administration, Oral; Adult; Affect; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucose; Humans; Male; Reaction Time; Serotonin; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tryptophan | 2005 |
Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.
Topics: Aged; Amitriptyline; Animals; Brain Chemistry; Depressive Disorder; Desipramine; Female; Humans; Infant; Infusions, Parenteral; Male; Middle Aged; Placebos; Prolactin; Rats; Receptors, Serotonin; Serotonin; Stimulation, Chemical; Substance Withdrawal Syndrome; Time Factors; Tryptophan | 1984 |
L-tryptophan: a rational hypnotic with clinical potential.
Topics: Animals; Brain Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Placebos; Rats; Serotonin; Sleep; Sleep Initiation and Maintenance Disorders; Stimulation, Chemical; Substance Withdrawal Syndrome; Tryptophan | 1977 |
Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy.
Topics: Adolescent; Adult; Anxiety; Behavior Therapy; Combined Modality Therapy; Diet; Dietary Carbohydrates; Humans; Middle Aged; Nicotine; Placebos; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tryptophan; Weight Gain | 1991 |
A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center.
Topics: Adolescent; Adult; Cocaine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; MMPI; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1990 |
38 other study(ies) available for tryptophan and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Topics: Alcohol Drinking; Alcoholism; Biomarkers; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenic Acid; Kynurenine; Neopterin; Quinolinic Acid; Substance Withdrawal Syndrome; Tryptophan | 2022 |
Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex.
Topics: Animals; Catalepsy; Dietary Supplements; Frontal Lobe; Haloperidol; Male; Rats; Rats, Wistar; Serotonin; Substance Withdrawal Syndrome; Tryptophan; Valine | 2009 |
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
Topics: Administration, Oral; Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents, Hormonal; Cysteine; Drug Administration Schedule; Flutamide; Humans; Male; Mice; Mutation; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Retreatment; Substance Withdrawal Syndrome; Tosyl Compounds; Transplantation, Heterologous; Tryptophan | 2010 |
Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.
Topics: Analgesics, Opioid; Animals; Astrocytes; Biomarkers; CD11b Antigen; Hyperalgesia; Male; Microglia; Morphine; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome; Tryptophan; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |
A rodent model of premenstrual dysphoria: progesterone withdrawal induces depression-like behavior that is differentially sensitive to classes of antidepressants.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Autoradiography; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Food Preferences; Hormones; Mood Disorders; Motor Activity; Nociception; Ovariectomy; Premenstrual Syndrome; Progesterone; Rats; Rats, Long-Evans; Serotonin; Serotonin Plasma Membrane Transport Proteins; Social Behavior; Substance Withdrawal Syndrome; Swimming; Tryptophan | 2012 |
Effects of potentiated antibodies against brain-specific S100 protein on biogenic amine content and lipid peroxidation in rats under conditions of alcoholization.
Topics: Animals; Antibodies; Biogenic Amines; Brain; Dopamine; Epinephrine; Ethanol; Lipid Peroxidation; Male; Norepinephrine; Rats; S100 Proteins; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 2003 |
Serotonin syndrome resulting from an herbal detox cocktail.
Topics: Adult; Antidepressive Agents, Second-Generation; Humans; Hypericum; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nonprescription Drugs; Plant Preparations; Self Medication; Serotonin Syndrome; Substance Withdrawal Syndrome; Tryptophan | 2004 |
Noncatecholaminergic treatments of tardive dyskinesia.
Topics: Amantadine; Anti-Anxiety Agents; Benzodiazepines; Cyproheptadine; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Double-Blind Method; Dyskinesia, Drug-Induced; Enkephalin, Methionine; gamma-Aminobutyric Acid; Humans; Lithium; Parasympathomimetics; Phenytoin; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, GABA-A; Substance Withdrawal Syndrome; Tryptophan | 1982 |
Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
Topics: Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Phenylacetates; Reference Values; Substance Withdrawal Syndrome; Tryptophan | 1981 |
The effect of long-term ethanol maternal ingestion and withdrawal on brain regional monoamine and amino acid precursors in 15-day-old rats.
Topics: Alcoholism; Amino Acids; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Female; Humans; Hydroxyindoleacetic Acid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan; Tyrosine | 1984 |
The role of central serotoninergic neurotransmission in the morphine abstinence syndrome in rats.
Topics: 5-Hydroxytryptophan; Animals; Brain; Fenclonine; Humans; Male; Metergoline; Morphine; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Synaptic Transmission; Tryptophan | 1983 |
Analytical methodology for assays of serum tryptophan metabolites in control subjects and newly abstinent alcoholics: preliminary investigation by liquid chromatography with amperometric detection.
Topics: Adult; Aged; Alcoholism; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Kynurenine; Male; Middle Aged; Serotonin; Spectrophotometry, Ultraviolet; Substance Withdrawal Syndrome; Tryptophan | 1984 |
Inhibition of rat brain tryptophan metabolism by ethanol withdrawal and possible involvement of the enhanced liver tryptophan pyrrolase activity.
Topics: Animals; Behavior, Animal; Brain; Corticosterone; Ethanol; Humans; Liver; Male; NAD; Rats; Serotonin; Substance Withdrawal Syndrome; Tryptophan; Tryptophan Oxygenase | 1980 |
The effects of ethanol on rat liver and brain tryptophan metabolism.
Topics: Alcoholism; Animals; Brain Chemistry; Corticosterone; Ethanol; Humans; Liver; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tryptophan; Tryptophan Oxygenase | 1980 |
The role of liver tryptophan pyrrolase in the opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on rat brain tryptophan metabolism.
Topics: Animals; Brain; Humans; Liver; Male; Methylphenazonium Methosulfate; Morphine; Naloxone; Nicotine; Phenobarbital; Rats; Substance Withdrawal Syndrome; Tryptophan; Tryptophan Oxygenase | 1981 |
24h withdrawal following repeated administration of caffeine attenuates brain serotonin but not tryptophan in rat brain: implications for caffeine-induced depression.
Topics: Analysis of Variance; Animals; Brain; Caffeine; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Hydroxyindoleacetic Acid; Male; Rats; Rats, Wistar; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan | 1995 |
Withdrawal from chronic cocaine administration causes prolonged deficits in L-tryptophan-induced head-twitch response in mice.
Topics: Analysis of Variance; Animals; Cocaine; Drug Administration Schedule; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Opioid-Related Disorders; Serotonin; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine; Tryptophan | 1997 |
Differential effects of monoaminergic agonists on alcohol intake in rats fed a tryptophan-enhanced diet.
Topics: Alcohol Drinking; Amphetamine; Animals; Appetite Depressants; Cerebral Cortex; Corpus Striatum; Dopamine; Fenfluramine; Food, Formulated; Hypothalamus; Phentermine; Rats; Rats, Long-Evans; Serotonin; Substance Withdrawal Syndrome; Tryptophan | 1999 |
The effects of acute and chronic nicotine hydrogen (+)-tartrate administration and subsequent withdrawal on rat liver tryptophan pyrrolase activity and their comparison with those of morphine, phenobarbitone and ethanol.
Topics: Animals; Cycloheximide; Dactinomycin; Ethanol; Humans; Hydrocortisone; Liver; Male; Morphine; NADP; Nicotinyl Alcohol; Phenobarbital; Premedication; Pyridines; Rats; Substance Withdrawal Syndrome; Time Factors; Tryptophan; Tryptophan Oxygenase | 1975 |
Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.
Topics: Animals; Anti-Anxiety Agents; Brain; Bromazepam; Diazepam; Humans; Hydroxyindoleacetic Acid; Male; Mesencephalon; Monoamine Oxidase; Rats; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan; Tryptophan Hydroxylase | 1977 |
Neurochemical correlates of ethanol withdrawal: alterations in serotoninergic function.
Topics: Alcoholism; Animals; Brain Chemistry; Brain Stem; Humans; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Pargyline; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan | 1977 |
A pyridoxine-dependent behavioral disorder unmasked by isoniazid.
Topics: Child Behavior Disorders; Child, Preschool; Female; Humans; Hyperkinesis; Isoniazid; Kynurenine; Niacinamide; Pyridoxine; Substance Withdrawal Syndrome; Tryptophan | 1978 |
Sleep and behavioral changes possibly reflecting central receptor hypersensitivity following catecholamine synthesis inhibition in man.
Topics: Behavior; Bipolar Disorder; Dopamine; Humans; Levodopa; Norepinephrine; Receptors, Neurotransmitter; Sleep; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 1977 |
Measures of physical dependence and involvement of serotonin in withdrawal symptomatology.
Topics: Alcoholism; Animals; Body Temperature; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Serotonin; Substance Withdrawal Syndrome; Tryptophan | 1977 |
Alteration in serum tyrosine and tryptophan concentrations associated with the induction of physical dependence on ethanol in mice.
Topics: Alcoholism; Animals; Humans; Male; Mice; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 1978 |
The effects of ethanol on tryptophan pyrrolase activity and their comparison with those of phenobarbitone and morphine.
Topics: Animals; Cricetinae; Ethanol; Fatty Acids, Nonesterified; Guinea Pigs; Humans; Kynurenine; Liver; Male; Morphine; Phenobarbital; Rats; Species Specificity; Substance Withdrawal Syndrome; Tryptophan; Tryptophan Oxygenase | 1975 |
Is quinolinic acid an endogenous excitotoxin in alcohol withdrawal?
Topics: Alcoholism; Animals; Brain; Humans; Kynurenic Acid; Models, Neurological; Quinolinic Acid; Quinolinic Acids; Substance Withdrawal Syndrome; Synaptic Transmission; Tryptophan | 1991 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1990 |
Treatment of depression with pumpkin seeds.
Topics: Adult; Depressive Disorder; Fruit; Humans; Male; Seeds; Substance Withdrawal Syndrome; Tryptophan | 1990 |
Cocaine withdrawal. An effective three-drug regimen.
Topics: Amantadine; Cocaine; Humans; Lorazepam; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan | 1989 |
Evaluation of L-tryptophan for treatment of insomnia: a review.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Drug Tolerance; Ethanol; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Oxprenolol; Reaction Time; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Tryptophan | 1986 |
Effects of alcohol on tryptophan metabolism.
Topics: Animals; Ethanol; Humans; Rats; Serotonin; Substance Withdrawal Syndrome; Tryptophan | 1988 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission.
Topics: 5-Hydroxytryptophan; Acetates; Aminobutyrates; Animals; Atropine; Ethanol; Fenclonine; Humans; Male; Methyltyrosines; Mice; Neurotransmitter Agents; Nialamide; Phentolamine; Physostigmine; Picrotoxin; Propranolol; Pyrazoles; Reserpine; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan | 1973 |
The effects of chronic phenobarbitone administration and subsequent withdrawal on the activity of rat liver tryptohan pyrrolase and their resemblance to those of ethanol.
Topics: Animals; Depression, Chemical; Ethanol; Humans; Hydrocortisone; Injections, Intraperitoneal; Kynurenine; Liver; NAD; NADP; Phenobarbital; Rats; Sodium Chloride; Sodium Salicylate; Substance Withdrawal Syndrome; Time Factors; Tryptophan; Tryptophan Oxygenase | 1973 |
Physical dependence on morphine fails to increase serotonin turnover rate in rat brain.
Topics: Animals; Body Temperature; Brain; Carbon Isotopes; Fenclonine; Humans; Male; Mathematics; Morphine Dependence; Nalorphine; Norepinephrine; Rats; Serotonin; Substance Withdrawal Syndrome; Tritium; Tryptophan; Tyrosine | 1971 |
Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
Topics: Animals; Body Weight; Brain Chemistry; Drug Interactions; Female; Fenclonine; Humans; Kinetics; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Motor Activity; Naloxone; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1971 |
The effects of drugs on barbiturate withdrawal convulsions in the rat.
Topics: Animals; Barbiturates; Chlordiazepoxide; Chlorpromazine; Ethanol; Ethosuximide; Female; Humans; Hydrazines; Hypnotics and Sedatives; Meprobamate; Methyltyrosines; Monoamine Oxidase Inhibitors; Morphine; Phenylalanine; Primidone; Rats; Reserpine; Seizures; Serotonin; Substance Withdrawal Syndrome; Tryptophan | 1970 |